• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Generation of anti-influenza aptamers using systematic evolution of ligands by exponential enrichment for sensing applications

tetano

Editor, Senior Moderator
Langmuir. 2013 Nov 7. [Epub ahead of print]
Generation of anti-influenza aptamers using systematic evolution of ligands by exponential enrichment for sensing applications.
Thangavel L, Fujimaki M, Gopinath SC, Awazu K.
Abstract

Systematic evolution of ligands by exponential enrichment (SELEX) is a selection process for identifying high-affinity selective molecules from a randomized combinatorial nucleic acid library against a wide range of target molecules. Using a pool of N25 RNA molecules, the SELEX process was performed against two targets from influenza viruses, namely, intact influenza B/Tokio/53/99 and hemagglutinin of infuluenza B Jilin/20/2003. The selection processes were evaluated by surface plasmon fluorescence spectroscopy (SPFS), and the result was compared with that obtained by a conventional radioisotope method. Clear discriminations among different selection cycles were displayed by SPFS, indicating that this method can be used as an alternative method of radioisotope labeling. The dissociation constant of the selected aptamers against the targets was in the low nanomolar range. The sensitivity of the selected aptamer against intact influenza B/Tokio/53/99 to detect the influenza virus was low ng/mL level, approximately 250-fold higher sensitivity than that of the commercially obtained antibody. The target-binding sites on the aptamer were predicted by mapping analyses. The selected aptamer could discriminate other influenza strains and the sensitivity of the selected aptamer was further confirmed by gold nanoparticle-based sensing on a waveguide-mode sensor. This finding demonstrates that the selected aptamer would be useful for detecting influenza viruses at an early stage of infection and for the purpose of influenza surveillance.

PMID:
24200095
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24200095
 
Back
Top Bottom